Don’t overstate the improtance of treatment guidelines Newsletter Article 11 February 2013 Pages: 2 - 2
Performance reporting essential in healthcare management Newsletter Article 11 February 2013 Pages: 2 - 2
Telemanagement minimises hospitalisation for CHF Amanda Cameron Newsletter Article 11 February 2013 Pages: 3 - 4
Address the right questions when conducting economic evaluations Newsletter Article 11 February 2013 Pages: 5 - 5
Self-management cost effective vs traditional asthma therapy Newsletter Article 11 February 2013 Pages: 6 - 6
Pharmaceutical care programme reduces ADRs and drug costs Newsletter Article 11 February 2013 Pages: 6 - 6
Adjunctive radiotherapy justified in early-stage breast cancer Newsletter Article 11 February 2013 Pages: 7 - 7
Desflurane and sevoflurane do not increase anaesthesia costs Newsletter Article 11 February 2013 Pages: 7 - 7
Acarbose reduces bodyweight gain and CHD costs in type 2 diabetes Newsletter Article 11 February 2013 Pages: 8 - 8
Carve-out mental health plan cuts costs and improves access Newsletter Article 11 February 2013 Pages: 10 - 10
Don’t include QOL measures in all cancer clinical trials Newsletter Article 11 February 2013 Pages: 10 - 10
Foreign and domestic industry views on reference pricing in Japan Newsletter Article 11 February 2013 Pages: 11 - 11
Growth in US drug prices decreased between 1993 and 1997 Newsletter Article 11 February 2013 Pages: 11 - 11